Pubblicazioni

Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo

2024 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Guttman-Yassky, E.; Del Duca, E.; Da Rosa, J. C.; Bar, J.; Ezzedine, K.; Ye, Z.; He, W.; Hyde, C.; Hassan-Zahraee, M.; Yamaguchi, Y.; Peeva, E.

Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis

2023 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Guttman-Yassky, E.; Facheris, P.; Da Rosa, J. C.; Rothenberg-Lausell, C.; del Duca, E.; David, E.; Estrada, Y.; Liu, Y.; Bose, S.; Chowdhury, M.; Munera, C.; Goncalves, J.; Nograles, K.; Kim, B. S.; Lebwohl, M.

Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers

2022 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Guttman-Yassky, E.; Pavel, A. B.; Diaz, A.; Zhang, N.; Del Duca, E.; Estrada, Y.; King, B.; Banerjee, A.; Banfield, C.; Cox, L. A.; Dowty, M. E.; Page, K.; Vincent, M. S.; Zhang, W.; Zhu, L.; Peeva, E.

The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults

2021 - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Renert-Yuval, Y.; Del Duca, E.; Pavel, A. B.; Fang, M.; Lefferdink, R.; Wu, J.; Diaz, A.; Estrada, Y. D.; Canter, T.; Zhang, N.; Wagner, A.; Chamlin, S.; Krueger, J. G.; Guttman-Yassky, E.; Paller, A. S.